. Open DMs.
Nasdaq-listed BioNTech up 10% in pre-market trading, while vaccine development partner Pfizer is up >5%. Pfizer boss calls it “a great day for science and humanity”.
Pokaż ten wątek
BREAKING: 
@BioNTech_Group’s vaccine found to be 90% effective in protecting against Covid-19, vastly exceeding regulatory criteria, and putting it on track for approval in the EU and US within weeks.
The company says it can manufacture 50m doses this year, and 1.3bn in 2021.
-
-
-
“This is an important step for science, the data showed that a vaccine can work," Ugur Sahin, co-founder and chief executive of BioNTech told the FT. “The likelihood that other vaccines are going to be also successful increased today”.
Pokaż ten wątek -
Worth noting that several countries have already secured doses of the vaccine (which requires a booster shot).
200m doses, currently under negotiation
100m doses (with an option to acquire another 500m)
120m
30m
... among othersPokaż ten wątek -
BioNTech's boss told the FT the companies would “use a fair approach” when it came to distributing the first doses of the vaccine, adding that they would prioritise deliveries to countries where it had been approved for use. (Which looks like US and EU first).
Pokaż ten wątek
Koniec rozmowy
Nowa rozmowa -
-
-
Next challenge is to make people trust it
-
Genau!
Koniec rozmowy
Nowa rozmowa -
-
-
@LorenzAdlung wollen wir uns mal die Paper dazu anschauen? Bin neugierig auf die Statistik usw -
wenn die zugänglich sind, gern
- Pokaż odpowiedzi
Nowa rozmowa -
-
-
Two things that should never rush in life science and sex
-
The French would put lunch before both
- Pokaż odpowiedzi
Nowa rozmowa -
Wydaje się, że ładowanie zajmuje dużo czasu.
Twitter jest przeciążony lub wystąpił chwilowy problem. Spróbuj ponownie lub sprawdź status Twittera, aby uzyskać więcej informacji.